Varenicline standards and impurity controls

A composition and drug technology, applied in the fields of cognitive dysfunction, amyotrophic lateral sclerosis, jet lag, and sleep disorders, can solve cumbersome problems and the like

Inactive Publication Date: 2009-04-15
PFIZER PRODS ETAT DE CONNECTICUT
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the absence of synthetic standards, the process of op...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Varenicline standards and impurity controls
  • Varenicline standards and impurity controls
  • Varenicline standards and impurity controls

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0088] Part A: Example Clearance Experiments

[0089] Experimental Determination of Fold Clearance: Synthesis of Varenicline

[0090] Compound 8 was slurried in toluene and added to an aqueous solution of NaOH (3.1 equiv). The biphasic mixture was heated to 37-40°C, whereupon two clear yellowish layers resulted. At this point, 50 ppm of compound 3 (R=H) was spiked into the reaction mixture. The conversion of compound 8 to varenicline (9) was then carried out, including treating the biphasic toluene / water phase with Darco KB-B and recovering the compound 9 / toluene solution. The compound 9 / toluene solution was azeotroped with MeOH. The resulting compound 9 / methanol solution was added to the L-(+)-tartaric acid / MeOH solution to form salt 10. After the granules were formed, Salt 10 was filtered and dried.

[0091] The isolated material was analyzed for residual compound 3 (R=H). When a temperature of 37-40°C was reached, 50 ppm of Blend 3 was introduced into the reaction mix...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The subject invention provides a varenicline composition that comprises varenicline, or a pharmaceutically acceptable salt thereof, and an amount of a compound selected from one or more of several mononitro, monoamine mixed aminonitro, diamino or dinitro intermediates, and the concentration of said compound is greater than 0 ppm and not greater than about 500 ppm, not greater than about 100 ppm or not greater than about 10 ppm. Methods for synthesizing and using such varenicline compositions are also provided.

Description

Background technique [0001] Efforts are made to prepare high grade pharmaceutical products with the least amount of impurities present. The control of impurities requires the study of various options for the reaction conditions and testing protocols necessary to ensure that the drug product administered to the public is pure. [0002] Guidance given by regulatory agencies, including the U.S. Food and Drug Administration (FDA), states that for a drug substance at a dose of 2 g / day or less, if an impurity in the drug substance, if present, is present at 0.1% (i.e. 1000ppm) or higher should be identified. (Note that ppm is parts per million, so 1% = 10,000 ppm; 0.1% = 1000 ppm; 0.01% = 100 ppm; 0.001% = 10 ppm). For example, the FDA has indicated that for a drug substance dosed at 2 g / day, it is generally considered unnecessary to identify impurities at apparent levels below 0.1% (Federal Register, 65 (140), 45085-45090, 45086 and 45089 (20 July 2000). However, FDA also notes...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/439A61K31/498A61P25/00A61P25/34A61P1/00A61P9/00A61P3/00
Inventor 卡伦·S·布朗克弗兰克·R·布希特里·G·西奈格雷戈里·J·威思布罗
Owner PFIZER PRODS ETAT DE CONNECTICUT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap